ALXP
ALMDT
Market cap243mUSD
Oct 28, Last price
4.45EUR
1D
-0.11%
1Q
10.02%
Jan 2017
-59.59%
IPO
-54.41%
Name
Median Technologies SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Valbonne, France, Median Technologies S.A. was established in 2002. This company specializes in developing and commercializing advanced software and platforms designed for medical image analysis. Its reach extends globally, serving markets in France, the United States, Canada, the United Kingdom, China, and beyond. Among its key offerings is iBiops, an innovative, AI-powered software classified as a medical device. This solution comprehensively integrates and optimizes the entire medical imaging workflow. Additionally, Median Technologies provides iSee, a service dedicated to image analysis specifically for clinical trials. Furthermore, the company delivers extensive imaging contract research organization (CRO) services. These encompass a wide range of activities, from study initiation and the management of both image and clinical data, to scientific advisory, independent reviews, image data processing, site support, and final study close-out. Solidifying its commitment to research, Median Technologies maintains a collaborative agreement with the University of California.
Key people
Fredrik Brag
Chief Executive Officer · since 2019
Bernard Reymann
Chief Financial Officer
Gerard Milhiet
Executive Vice President, Director · since 2017
Nohza Boujemaa
Chief Science and Innovation Officer · since 2018
Michael Auffret
Vice President of Product Management & Regulatory
Nicholas Campbell
Chief Commercial Officer · since 2016
Director
Jeanne Hecht
Chief Operating Officer, Director · since 2017
Oran E. Muduroglu
Chairman of the Board · since 2019
Director
Headquarters & legal address
1800 ROUTE DES CRETES
LES DEUX ARCS
VALBONNE 06560
FR
LES DEUX ARCS
VALBONNE 06560
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |